Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Receivables: 2020-2023

Historic Receivables for Immuneering (IMRX) over the last 2 years, with Mar 2023 value amounting to $1,046.

  • Immuneering's Receivables fell 99.63% to $1,046 in Q1 2023 from the same period last year, while for Mar 2023 it was $262,068, marking a year-over-year decrease of 82.44%. This contributed to the annual value of $12,417 for FY2022, which is 94.95% down from last year.
  • Per Immuneering's latest filing, its Receivables stood at $1,046 for Q1 2023, which was down 91.58% from $12,417 recorded in Q4 2022.
  • Immuneering's 5-year Receivables high stood at $500,110 for Q4 2020, and its period low was $1,046 during Q1 2023.
  • Its 3-year average for Receivables is $219,275, with a median of $212,232 in 2021.
  • Data for Immuneering's Receivables shows a maximum YoY crashed of 99.63% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Immuneering's Receivables stood at $500,110 in 2020, then plummeted by 50.80% to $246,040 in 2021, then plummeted by 94.95% to $12,417 in 2022, then tumbled by 99.63% to $1,046 in 2023.
  • Its last three reported values are $1,046 in Q1 2023, $12,417 for Q4 2022, and $70,180 during Q3 2022.